학술논문

Mobile application for monitoring patients under home oxygen therapy: a protocol for a randomized controlled trial
Document Type
article
Source
BMC Family Practice, Vol 22, Iss 1, Pp 1-10 (2021)
Subject
Oxygen therapy
COPD
E-Health
Mobile applications
Home healthcare
Medicine (General)
R5-920
Language
English
ISSN
1471-2296
Abstract
Abstract Background Mobile technologies have become capable of changing the paradigm of healthcare services. A clear example is that, nowadays, these technologies are an important instrument for data collection processes, epidemiologic surveillance, health promotion and disease prevention. Therefore, technological tools should be exploited to optimize the monitoring of patients with chronic diseases, including patients who require home oxygen therapy. Purpose: The purpose of this study is to determine the efficacy of a mobile application in the clinical monitoring of patients under home oxygen therapy. Methods This is a randomized controlled trial includes subjects of 18 years or older diagnosed with Chronic Obstructive Pulmonary Disease (COPD) who are under home oxygen therapy. Subjects will be divided into two arms: the intervention group will include patients who will be monitored with a mobile application, and the control group will include patients monitored by conventional follow-up methods (periodic visits of a respiratory therapist). The following outcome variables will be considered to measure the effect of the intervention: identification of dyspnea self-management, number of acute exacerbations associated with oxygen therapy, and the occurrence of oxygen supply underuse. Discussion This study is expected to assess the efficacy of a mobile application in the follow up of patients under home oxygen therapy. It will also determine whether the monitoring of a six-month intervention by a team comprising a physician, a nurse and respiratory therapists can decrease acute exacerbations, determine the most appropriate oxygen dose, and identify the underuse of oxygen systems and supplies. Trial registration The study has been registered at ClinicalTrials.gov ( NCT04820790 ; date of registration: March 29, 2021)